
November/December 2015—Advances in immune therapy may change how scientists and clinicians understand neurodegenerative components of MS.
October 2015—Current immunomodulatory treatments for MS are not reliable to prevent long-term disability, but future agents focusing on remyelination and axonal and neuronal repair could reverse this course.
October 2015—Depression and anxiety are both more prevalent in patients with MS than in the general population. Smoking and alcohol use are also common in these patients. However, while th…
October 2015— PRISMS-15 Study Identifies Factors Influencing Long-Term Outcomes in RRMS New findings from the PRISMS-15 study suggest that higher cumulative exposure to subcutaneous …
September 2015— New Evidence Ties Low Vitamin D Levels to Neurological Diseases Low levels of vitamin D have been associated with a variety of medical conditions in the last seve…
November/December 2014—New treatments have emerged and others are expected. What have changes meant for patient care?
November/December 2014—Researchers are focused on patient outcomes on a global scale and join clinicians in the vigil for new drug approvals.
November/December 2014—The ice bucket challenge may have been this year’s ALS headline story, but research is progressing on gene research.
For advertising rates and opportunities:
Wendy Terry
Publisher
217-652-3859
wterry@bmctoday.com
Launched in 2002, Practical Neurology is a publication uniquely dedicated to presenting current approaches to patient management, synthesis of emerging research and data, and analysis of industry news with a goal to facilitate practical application and improved clinical practice for all neurologists. Our straightforward articles give neurologists tools they can immediately put into practice.
We use cookies to offer a better user experience and to analyze site traffic. To comply with the European General Data Protection Regulation (GDPR), we are implementing a cookie consent manager to provide residents of the EU/EEA with the ability to customize their cookies. Until this is available, your continued use of this site will be deemed as consent to use of cookies.
Continue »